PD Dr. med. Götz Ulrich Grigoleit
Head of Department Hematology, Oncology and Immunology at Helios Hospital Duisburg
Specialist fields (in extracts)
Hematology:
- Diagnostics and treatment of malignant haematological diseases (acute leukaemia, myelodysplastic syndrome, chronic myeloproliferative neoplasia, malignant lymphomas, multiple myeloma, benign blood diseases)
- Autologous and allogeneic stem cell transplantation
- Hematological diagnostics including FISH, flow cytometry, cytology
Oncology:
- Diagnostics and pharmalogical treatment of all solid organ malignancies (including lung cancer, malignancies of the gastrointestine, malignancies of the central nervous system, breast cancer and gynecological malignancies, head-neck cancer)
Curriculum vitae (in extracts)
| December 2000
|
Medical license (Approbation)
|
| 2000-2005
|
Fellowship at the University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology and Immunology
|
| 2005-2012
|
Fellowship at the University Hospital Würzburg, department of Internal Medicine II
|
| 2008
|
Specialization in Internal Medicine: Attending physician at the University Hospital Würzburg, department of Internal Medicine II
|
| 2009
|
Specialization in hematology and medical oncology at the University Hospital Würzburg, department of Internal Medicine II
|
| 2012-2019
|
Head of division for allogeneic stem cell transplantation at the University Hospital Würzburg, department of Internal Medicine II
|
| January 2015
|
Venia legendi (Habilitation) for Internal Medicine at the University of Würzburg awarded for „the donor immune system as basis for cellular immuno therapies against infections and hematological malignancies”
|
| Since October 2019
|
Head of Department Hematology, Oncology and Immunology at the Helios Hospital Duisburg
|
Extra information
Ongoing Research Projects:
Prophylactic Application of donor-derived Central memory T lymphocytes after allogeneic hematopoetic progenitor cell transplantation to prevent infectious complications (PACT): A prospective, first in man, open Phase I/IIa clinical trial
Advanced Concepts in Cellular Immune Control of Cytomegalovirus – P09 Personalized medicine – Risk stratification and prevention of HCMV-related disease in transplant patients based on MHC-I peptidome analysis (Deutsche Forschungsgemeinschaft)
Memberships
- European Society for Blood and Marrow Transplantation (EBMT)
- Deutsche Arbeitsgemeinschaften für Knochenmark- und Blutstammzelltransplantation e.V. (DAG-KBT)
- Studienallianz Leukämie (SAL)
Send Request
We speak german, english, russian, arabic and french
